Page last updated: 2024-08-16

ranitidine and Leukemia, Myeloid, Acute

ranitidine has been researched along with Leukemia, Myeloid, Acute in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Borthakur, G; Brail, L; Chow, KH; Cooley, S; Jackson, K; Moonan, L; Odenike, O; Rizzieri, DA; Wang, X	1
Assa'ad, A; Burns, K; Hershey, GK; Johnson, T; Lierl, MB; Metz, KA; Seidu, L	1
Brune, M; Hansson, M; Hellstrand, K; Hermodsson, S; Mellqvist, UH	1

Trials

1 trial(s) available for ranitidine and Leukemia, Myeloid, Acute

Article	Year
An open-label phase 2 study of glycogen synthase kinase-3 inhibitor LY2090314 in patients with acute leukemia. Leukemia & lymphoma, 2016, Volume: 57, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Anemia; Anti-Ulcer Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; beta Catenin; Bone Marrow Cells; Carboplatin; Chemotherapy-Induced Febrile Neutropenia; Cohort Studies; Female; Glycogen Synthase Kinase 3; Heterocyclic Compounds, 3-Ring; Humans; Leukemia, Myeloid, Acute; Leukocytes, Mononuclear; Male; Maleimides; Middle Aged; Pain, Procedural; Pemetrexed; Protein Kinase Inhibitors; Ranitidine; Thrombocytopenia	2016

Article

Year

An open-label phase 2 study of glycogen synthase kinase-3 inhibitor LY2090314 in patients with acute leukemia.

Leukemia & lymphoma, 2016, Volume: 57, Issue:8

Topics: Adult; Aged; Aged, 80 and over; Anemia; Anti-Ulcer Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; beta Catenin; Bone Marrow Cells; Carboplatin; Chemotherapy-Induced Febrile Neutropenia; Cohort Studies; Female; Glycogen Synthase Kinase 3; Heterocyclic Compounds, 3-Ring; Humans; Leukemia, Myeloid, Acute; Leukocytes, Mononuclear; Male; Maleimides; Middle Aged; Pain, Procedural; Pemetrexed; Protein Kinase Inhibitors; Ranitidine; Thrombocytopenia

2016

Other Studies

2 other study(ies) available for ranitidine and Leukemia, Myeloid, Acute

Article	Year
Successful administration of cytarabine in a 16-month-old girl with acute myelogenous leukemia and cytarabine syndrome. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2009, Volume: 102, Issue:2 Topics: Cytarabine; Diphenhydramine; Drug Hypersensitivity; Female; Histamine Antagonists; Humans; Immunosuppressive Agents; Infant; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Methylprednisolone; Premedication; Ranitidine; Syndrome; Treatment Outcome	2009
NK cell-mediated killing of AML blasts: role of histamine, monocytes and reactive oxygen metabolites. European journal of haematology, 1996, Volume: 57, Issue:4 Topics: Catalase; CD56 Antigen; Cytotoxicity, Immunologic; Histamine; Histamine H2 Antagonists; Humans; Immunity, Cellular; Immunotherapy; Interferon-alpha; Interleukin-2; Killer Cells, Natural; Leukemia, Myeloid, Acute; Monocytes; N-Formylmethionine Leucyl-Phenylalanine; Ranitidine; Reactive Oxygen Species; Receptors, Histamine H2; Tumor Cells, Cultured	1996

Article

Year

Successful administration of cytarabine in a 16-month-old girl with acute myelogenous leukemia and cytarabine syndrome.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2009, Volume: 102, Issue:2

Topics: Cytarabine; Diphenhydramine; Drug Hypersensitivity; Female; Histamine Antagonists; Humans; Immunosuppressive Agents; Infant; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Methylprednisolone; Premedication; Ranitidine; Syndrome; Treatment Outcome

2009

NK cell-mediated killing of AML blasts: role of histamine, monocytes and reactive oxygen metabolites.

European journal of haematology, 1996, Volume: 57, Issue:4

Topics: Catalase; CD56 Antigen; Cytotoxicity, Immunologic; Histamine; Histamine H2 Antagonists; Humans; Immunity, Cellular; Immunotherapy; Interferon-alpha; Interleukin-2; Killer Cells, Natural; Leukemia, Myeloid, Acute; Monocytes; N-Formylmethionine Leucyl-Phenylalanine; Ranitidine; Reactive Oxygen Species; Receptors, Histamine H2; Tumor Cells, Cultured

1996